Medicare AdvantageCoverageMedium impact
MA06.024i, Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver Disease
Independence Blue Cross·Gastroenterology, Internal Medicine, Family Medicine·Medical Policy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.024i regarding noninvasive techniques for chronic liver disease evaluation and monitoring has been reissued effective October 1, 2025. This is a policy update that may affect coverage criteria, billing requirements, or documentation standards for liver disease diagnostic procedures.
Action Required
By October 1, 2025: Clinical and billing teams should review the complete policy MA06.024i for any changes to coverage criteria, prior authorization requirements, or documentation standards for noninvasive liver disease evaluation procedures. Update billing protocols and provider workflows accordingly once full policy details are available.